glp 1 medications and depression GLP-1 Receptor Agonists in Mood Disorders: A Psychiatric Perspective Researchers find GLP-1 medications for

Important information about titration GLP-1 use must always be done with the approval of a certified healthcare professional

The study demonstrated non-inferior efficacy compared to the innovator drug, along with a comparable safety profile

About this article Cite this article Scheen, A.J

Viral Shah, an endocrinologist at Indiana University School of Medicine, told CNN in 2025 that people 65 and older are already at risk for sarcopenia, and losing even 10 to 15% of lean mass while on a GLP-1 is significant because they have less muscle to begin with

Evidence from Human Trials : There is a lack of substantial clinical trial data in human subjects, especially in PWS patients, which is necessary to confirm the efficacy and safety of PYY analog therapy in the intended population